DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Veltkamp SA, Kadokura T, Krauwinkel WJ. et al.
Effect of ipragliflozin (ASP1941), a novel selective sodium-dependent glucose co-transporter 2 inhibitor, on urinary glucose excretion in healthy subjects.
Clin Drug Investig 2011;
31: 839-851
We do not assume any responsibility for the contents of the web pages of other providers.